Relay Therapeutics, Inc. · NASDAQ:RLAY
Catinazzo Thomas sold 32,717 Relay Therapeutics, Inc. shares (Form 4)
Traded Nov 18, 2026 · Filed Nov 20, 2026
On Nov 18, 2026, Catinazzo Thomas (Chief Financial Officer) sold 32,717 Relay Therapeutics, Inc. shares at US$16.51 for US$540K under a trading plan, leaving 70,948 shares. Filed Nov 20, 2026 (Form 4).
- Sold
- 32,717 shares
- Price
- US$16.51
- Value
- US$540K
- Holding after
- 70,948 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 18, 2026 | Common Stock | Sale | 32,717 | US$16.51 | 70,948 | Direct |
Source
Download original · View original at SEC
Related
- Relay Therapeutics, Inc.
- Catinazzo Thomas
- Relay Therapeutics, Inc. shareholders
- Form 4 · Catinazzo Thomas · Oct 30, 2026
- Form 4 · Catinazzo Thomas · Oct 8, 2026
- Form 4 · Catinazzo Thomas · Sep 9, 2026
- Form 4 · Catinazzo Thomas · Aug 18, 2026
- Form 4 · Catinazzo Thomas · Jul 30, 2026
- Form 4 · Patel Sanjiv · Nov 20, 2026
- Form 4 · Bergstrom Donald A · Nov 20, 2026
- Schedule 13G · T. Rowe Price Investment Management, Inc. · Nov 16, 2026
- Schedule 13G/A · Sb Investment Advisers (UK) LTD · Nov 16, 2026
- Form 4 · Rahmer Peter · Oct 30, 2026